Search the Newsreel

Spire Global (SPIR) to Announce Earnings on Wednesday

Spire (NYSE:SR) Releases FY 2026 Earnings Guidance

Spire Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:SR) 2026-08-05

Spire Inc. (SR) more than doubles profit on discontinued gains and new debt

CORBY SPIRIT AND WINE LIMITED TO SELL LAMB'S RUM BRAND AND ASSETS TO STRENGTHEN STRATEGIC FOCUS

ACES trails MDIY on margins despite similar revenue

Inspire Medical Systems, Inc. Stock 12‑Month Price Target Raised to $60.33, Implies 16% Upside

Analysts have raised the average 12-month price target for Inspire Medical Systems, Inc. (INSP) stock from $51.43 to $60.33, indicating a potential 16% upside from its Aug. 3 closing price. This new target is based on estimates from 15 analysts, with individual forecasts ranging …

Inspire Medical Systems (NYSE: INSP) files Form 4 on RSU tax withholding

Inspire Medical Systems' Chief People Officer, Melissa Mann, filed a Form 4 detailing tax-withholding dispositions related to the vesting of Restricted Stock Units (RSUs). A total of 652 shares were withheld across two transactions on July 31, 2025, and July 31, 2026, to cover …

INSP Price Today: Inspire Medical Systems, Inc. Stock Price, Quote & Chart | MEXC

Inspire Medical Systems (INSP) Stock May Be A Bargain On Raised 2026 Guidance

Inspire Medical Systems (INSP) has experienced a significant stock price decline over the past three years, yet current valuations suggest the shares are either fairly valued or undervalued. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $56 per share, indicating the …

Why Are Inspire Medical Systems (INSP) Shares Soaring Today

Inspire Medical Systems (INSP) shares surged by 18.3% after the company reported better-than-expected quarterly results, raised its full-year guidance, and announced a new corporate restructuring initiative called Project Horizon. Oppenheimer upgraded the stock to Outperform with an $85 price target. This positive news follows …

Inspire Medical Systems (NYSE:INSP) Shares Gap Up on Earnings Beat

Is Inspire Medical Systems (INSP) Fairly Valued After Q2 Beats And Raised Guidance?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Why Inspire Medical Systems stock moved on Q2 earnings and guidance Inspire Medical Systems (INSP) caught investor attention after Q2 results that topped …

INSPIRE MEDICAL SYSTEMS INC : JP MORGAN RAISES TARGET PRICE TO $60 FROM $54

JP Morgan has increased its target price for Inspire Medical Systems Inc (INSP.N) to $60 from $54. This update reflects the analyst's revised outlook on the company's valuation. The article is a brief news alert from Reuters regarding this financial adjustment.

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

Inspire Medical Systems Inc (INSP) (Q2 2026) Earnings Call Highlights: Navigating Reimbursement ...

This article first appeared on GuruFocus. Revenue: $200.6 million, a decrease of 7.6% year-over-year, impacted by coding and reimbursement disruption. Adjusted Operating Margin: Declined, primarily due to unfavorable leverage from lower sales, partially offset by gross profit gains. Adjusted EBITDA Margin: Declined 90 basis …

United Spirits Limited Revenue Breakdown – NSE:UNITDSPR

Inspire Medical Systems earnings beat by $0.38, revenue topped estimates

Inspire Medical Systems (NYSE: INSP) exceeded analyst expectations for its second-quarter earnings, reporting an EPS of $0.14 against an estimated $-0.24. The company also surpassed revenue estimates, bringing in $200.6 million compared to the consensus of $194.67 million. Looking ahead, Inspire Medical Systems projects …

Earnings call transcript: Inspire Medical beats Q2 2026 estimates, shares jump

Inspire Medical Systems (INSP) surpassed Q2 2026 revenue and adjusted EPS estimates, leading to a significant jump in shares despite a 7.6% year-over-year revenue decline due to coding and reimbursement issues. The company introduced "Project Horizon," a strategic growth plan to optimize operations and …

Inspire Medical Q2 Returns To Profit, Raises FY26 Outlook

(RTTNews) - Inspire Medical Systems, Inc. (INSP) on Monday reported a return to profitability in the second quarter. For the second quarter, revenue decreased to $200.6 million from $217.1 million a year earlier. Net earnings were $0.3 million, compared with a net loss of …

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

Inspire Medical Systems (INSP) reported $200.58 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 7.6%. EPS of $0.14 for the same period compares to $0.45 a year ago. The reported revenue represents a surprise of +2.95% over the …

Inspired Entertainment, Inc expected to post earnings of 4 cents a share - Earnings Preview

Inspired Entertainment, Inc is projected to report earnings of 4 cents per share. This information comes from a Refinitiv earnings preview. The full article content is behind a paywall on TradingView.

Inspire Medical Systems Q2 Adjusted Earnings, Revenue Fall; Raises 2026 Revenue Guidance

Inspire Medical Systems reported a decrease in Q2 adjusted earnings and revenue but exceeded FactSet estimates. The company posted adjusted EPS of $0.14 against an estimated $-0.24, and Q2 revenue of $200.6 million against an estimated $194.7 million. Despite the fall in adjusted earnings …

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Inspire Medical Systems announced its second-quarter 2026 financial results, reporting revenue of $200.6 million and diluted EPS of $0.01. The company raised its full-year 2026 revenue guidance to $835 million to $875 million and introduced "Project Horizon," a strategic growth plan designed to generate …

[10-Q] Inspire Medical Systems, Inc. Quarterly Earnings Report

Inspire Medical Q2 revenue falls to $200.6 million as guidance raised

Inspire Medical (INSP) reported second-quarter 2026 revenue of $200.6 million, a 7.6% decrease year-over-year, with net earnings of $0.3 million. Despite the revenue fall, the company raised its full-year 2026 revenue outlook to $835 million to $875 million and announced "Project Horizon," a strategic …

Inspire Medical Systems (NYSE:INSP) Issues Earnings Results, Beats Expectations By $0.38 EPS

Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimates

Inspire Medical Systems (NYSE:INSP) Reports Bullish Q2 CY2026, Stock Jumps 13.6%

Inspire Medical Systems (NYSE:INSP) Reports Bullish Q2 CY2026, Stock Jumps 13.6% Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q2 CY2026 results exceeding the market's revenue expectations , but sales fell by 7.6% year on year to $200.6 million. The company's full-year revenue guidance …

What To Expect From Inspire Medical Systems’s (INSP) Q2 Earnings

Inspire Medical Systems (INSP) is scheduled to announce its Q2 earnings this Monday after the bell. Analysts expect a 10.3% year-on-year revenue decline, despite the company's history of exceeding expectations. Its peers, Bausch + Lomb and Baxter, recently reported stronger-than-anticipated Q2 results.

Spire (SR) Dividend Hike Keeps Income Story Alive As Undervalued View Holds

Spire (SR) recently announced a quarterly dividend increase to $0.825 per share, extending its long history of uninterrupted payouts since 1946 and marking its 23rd consecutive year of annual dividend raises. Despite a recent share price pullback, analysts view Spire as undervalued, with a …

SR6238310 Bond Coupon Profile — Rate & Payments

This article provides a bond coupon profile for SR6238310, issued by Spire Inc., detailing its coupon rate and payment schedule. The bond has a current coupon rate of 6.25%, with the next interest payment scheduled for December 1, 2026. It highlights the importance of …

NSPR|InspireMD Inc|Price:0.654|Chg%:-0.018

This article provides a comprehensive stock analysis of InspireMD Inc (NSPR) by TradingKey, assigning it a "relatively very healthy" fundamental score and high growth potential, though its valuation is deemed "fairly valued." Key insights include high institutional ownership, multiple "Buy" ratings from analysts with …

BrightSpire Capital, Inc. Revenue Breakdown – NYSE:BRSP

InspireMD Eliminates Chief Commercial Officer Position

InspireMD has eliminated the position of Chief Commercial Officer, effective July 31, 2026, with Shane Gleason's employment ending on that date. This change signals a potential shift in the company's commercial strategy or organizational priorities. While the most recent analyst rating is a Buy …

Vanguard Portfolio Management (INSP) discloses 2.13M-share, 7.37% stake in Inspire

Vanguard Portfolio Management LLC has disclosed an amended 7.37% beneficial ownership stake in Inspire Medical Systems Inc., totaling 2,126,116 shares. The filing indicates Vanguard has sole voting power over 37,155 shares and sole dispositive power over all 2,126,116 shares, held across various Vanguard funds …